Skeletal Muscle Cells Derived from Induced Pluripotent Stem Cells: A Platform for Limb Girdle Muscular Dystrophies.
Celine BrugeMarine GeoffroyManon BenabidesEmilie PellierEvelyne GicquelJamila DhiabLucile HochIsabelle RichardXavier NissanPublished in: Biomedicines (2022)
Limb girdle muscular dystrophies (LGMD), caused by mutations in 29 different genes, are the fourth most prevalent group of genetic muscle diseases. Although the link between LGMD and its genetic origins has been determined, LGMD still represent an unmet medical need. Here, we describe a platform for modeling LGMD based on the use of human induced pluripotent stem cells (hiPSC). Thanks to the self-renewing and pluripotency properties of hiPSC, this platform provides a renewable and an alternative source of skeletal muscle cells (skMC) to primary, immortalized, or overexpressing cells. We report that skMC derived from hiPSC express the majority of the genes and proteins that cause LGMD. As a proof of concept, we demonstrate the importance of this cellular model for studying LGMDR9 by evaluating disease-specific phenotypes in skMC derived from hiPSC obtained from four patients.
Keyphrases
- induced pluripotent stem cells
- skeletal muscle
- induced apoptosis
- cell cycle arrest
- genome wide
- high throughput
- insulin resistance
- healthcare
- signaling pathway
- oxidative stress
- endothelial cells
- cell death
- gene expression
- muscular dystrophy
- metabolic syndrome
- adipose tissue
- type diabetes
- resistance training
- prognostic factors
- bioinformatics analysis
- genome wide identification